News & Updates
Filter by Specialty:
Sofosbuvir easy on the kidneys
Use of sofosbuvir-based direct-acting antiviral regimens for treating hepatitis C virus (HCV) in clinical trial participants with chronic kidney disease (CKD) does not appear to worsen estimated glomerular filtration rate levels, according to a study. Furthermore, the drug does not appear to contribute to an increased risk of end-stage renal disease among HCV patients with CKD treated in clinical practice.
Sofosbuvir easy on the kidneys
15 Mar 2022Polypharmacy in IBD interferes with treatment adherence, therapeutic success
Polypharmacy (PP) arises in nearly one in five patients with inflammatory bowel disease (IBD), particularly in older adults and those with comorbidity, according to a study, adding that PP can complicate adherence to treatment and therapeutic success.
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022L-arginine, tadalafil boost Li-ESWT effect for ED
In men with erectile dysfunction (ED), adjuvant daily oral therapy with L-arginine and tadalafil was effective and safe in enhancing the efficacy and duration of benefits of low-intensity extracorporeal shockwave therapy (Li-ESWT), a study has shown.
L-arginine, tadalafil boost Li-ESWT effect for ED
14 Mar 2022People who trust formal information source more likely to get COVID-19 jab
Among middle-aged and older adults, trust in formal sources of vaccine information, such as government agencies, is a strong predictor of willingness to get vaccinated against the coronavirus disease 2019 (COVID-19), according to a recent Singapore study.